BIG PHARMA EARNINGS WATCH: ELI LILLY AND NOVO NORDISK

GLP-1 Weight-Loss Leaders “Blow Past” Wall Street Projections in Q4 2023, Hike Prices on at Least 20 Brand Name Products in First Weeks of 2024 Big Pharma giants Eli Lilly and Novo Nordisk

02-22-2024 Read More

BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB AND ABBVIE

More Big Pharma Giants Report Earnings That Top Wall Street Expectations While Continuing to Hike Prices on Dozens of Brand Name Drugs Merck, Bristol Myers Squibb

02-15-2024 Read More

DOSE OF REALITY: BIG PHARMA CEOS FACE A RECKONING FROM LAWMAKERS AND EXPERTS ON ANTI-COMPETITIVE PRACTICES AND PRICE GOUGING

Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices High Takes Center Stage at HELP Committee Hearing On Thursday, the U.S. Senate Committee on Health, Education, Labor and

02-12-2024 Read More

BIG PHARMA EARNINGS WATCH: PFIZER & GLAXOSMITHKLINE

Big Pharma Giants Continue Q4 Earnings Besting Wall Street Expectations Pfizer and GlaxoSmithKline (GSK) are the latest Big Pharma giants to report Wall Street-besting earnings for the fourth

02-9-2024 Read More

DOSE OF REALITY: BIG PHARMA BUILDING PATENT THICKETS DISCONNECTED FROM ACTUAL INNOVATION TO CREATE NEW MONOPOLIES ON GLP-1 WEIGHT LOSS DRUGS

JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs Significantly Lower than for Other Prescription Drugs That Rely on Drug-Device Combinations A new analysis published in JAMA

02-8-2024 Read More

Advisory: Panel Discussion on Big Pharma’s Patent Abuse with CSRxP Executive Director Lauren Aronson

Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable for Anti-Competitive Tactics That Keep Drug Prices High For Immediate Release Contact: Jon Conradi 860-235-3884

02-6-2024 Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Big Pharma Giant Kicks Off Q4 Earnings After Hiking Prices More Than 40 Times in 2023 This past week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings

01-31-2024 Read More

DOSE OF REALITY: BIG PHARMA’S EGREGIOUS PRICING PRACTICES AND ANTI-COMPETITIVE TACTICS DRIVE HIGHER HEALTH CARE COSTS

Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive Costs on Patients, Taxpayers, and the U.S. Health Care System Tomorrow, the U.S.

01-30-2024 Read More

BIG PHARMA WATCH: AARP REPORT SHINES LIGHT ON SCALE AND COST OF BIG PHARMA’S PRICE HIKES THAT EXCEED INFLATION

Rx Price Watch Analysis Finds Big Pharma Price Increases Outpaced Inflation Every Year Except One Between 2006 and 2020 A new report from AARP finds Big Pharma “consistently” increased prices

01-19-2024 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.